Research Article
BibTex RIS Cite

Çocukluk çağında akut lösemi tanısı alan hastaların sonuçları ve akım sitometri ile değerlendirilmesi

Year 2021, Volume: 46 Issue: 1, 149 - 159, 31.03.2021

Abstract

Amaç: Bu çalışmada; çocukluk çağı akut lösemi hastalarının sonuçlarının ve akım sitometri sonuçlarının değerlendirilmesi, prognoz ve diğer klinik durumlar ile ilişkisinin araştırılması planlandı.
Gereç ve Yöntem: Bu çalışmaya, Ocak 2008 ile Kasım 2013 arasında hastanemizde tanı alan 69 akut lenfoblastik lösemi (ALL) ve 24 akut miyeloid lösemi (AML) hastası olmak üzere toplam 93 hasta dahil edildi.
Bulgular: Çalışmamızda, ALL hastalarında 5 yıllık genel sağkalım (OS) % 66, AML hastalarında ise % 80 saptandı. Lösemi hastaları, akım sitometrik olarak yüzey antijenlerine (CD) göre sınıflandırıldığında; CD2(+) hastalarda 5 yıllık OS % 77, CD2(-) hastalarda ise % 58 idi. CD10(+) hastalarda, 5 yıllık OS % 82, CD10(-) olan hastalarda ise % 61 idi. Ancak, sonuçlar istatistiksel olarak anlamlı değildi (p>0.05). ALL hastaları, T ve B hücre belirteçleri pozitif ALL olarak iki gruba ayrılarak değerlendirildi; T hücre belirteçleri pozitif ALL hastalarının 5 yıllık OS’leri, B hücre belirteçleri pozitif ALL hastalarına göre daha düşük saptandı (sırasıyla % 59 ve % 75) (p=0.518). AML hastaları ise lenfoid belirteçleri pozitif ve negatif AML olarak iki gruba ayrıldı, lenfoid belirteçleri pozitif AML hastalarının 5 yıllık OS’leri, lenfoid belirteçleri negatif olanlara göre daha yüksek saptandı (sırasıyla % 83 ve %70) (p=0.638). Bu sonuçlar istatistiksel olarak anlamlı değildi.
Sonuç: Lösemi hastalarımızın akım sitometri ile değerlendirilmesinde, CD10(+) olan hastaların 5 yıllık OS’lerinin daha iyi olduğu, CD2(+) olan hastalarda ise daha düşük olduğu saptandı. ALL hastalarında B hücre belirteçleri pozitif hastaların, AML hastalarında ise lenfoid belirteçleri pozitif hastaların sonuçları daha iyi idi.

References

  • References1. McKenney AH, Cleary ML, Arber DA. Pathology and Molecular Diagnosis of Leukemias and Lymphomas. In: Pizzo PA, Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;113-30.
  • References2. Rabin KR, Gramatges MM, Margolin JF, Poplack DG. Acute Lymphoblastic Leukemia. In Pizzo PA, Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;463-97.
  • References3. Arceci RJ, Meshinchi S. Acute Myeloid Leukemia and Myelodysplastic Syndromes. In: Pizzo PA and Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;498-544.

Flow cytometric evaluation and outcomes of pediatric acute leukemia patients

Year 2021, Volume: 46 Issue: 1, 149 - 159, 31.03.2021

Abstract

Purpose: In this study, the outcomes and flow cytometry results of childhood acute leukemia patients and their relationship with the prognosis and other clinical conditions was investigated.
Materials and Methods: A total of 93 patients, including 69 acute lymphoblastic leukemia (ALL) and 24 acute myeloid leukemia (AML) patients diagnosed at our hospital between January 2008 and November 2013, were included.
Results: 5-year overall survival (OS) was 66% in ALL patients and 80% in AML patients. When leukemia patients were classified flow cytometrically according to their cell surface antigens (CD); 5-year OS was 77% in CD2(+) patients and 58% in CD2(-) patients. Five-year OS was 82% in patients with CD10(+) and 61% in patients with CD10(-). However, the results were not statistically significant (p>0.05). ALL patients were divided into two groups as ALL with positive T cell markers and ALL with positive B cell markers in the foreground and evaluated accordingly, and the OS of ALL patients with positive T cell markers in the foreground was lower than ALL patients with positive B cell markers in the 5 year (59% and 75%, respectively) (p =0.518). On the other hand, AML patients were divided into two groups as AML with positive lymphoid markers and AML with negative lymphoid markers, and the 5 year OS of AML patients with positive lymphoid markers was higher than AML patients with negative lymphoid markers (83% and 70%, respectively) (p = 0.638). These results were not statistically significant.
Conclusion: In the flow cytometric evaluation of our patients with leukemia, it was found that patients with CD10(+) had a better 5-year OS and patients with CD2(+) had a lower 5-year OS. The results of patients with positive B cell markers were better in ALL patients, and the results of patients with positive lymphoid markers were better in AML patients.

References

  • References1. McKenney AH, Cleary ML, Arber DA. Pathology and Molecular Diagnosis of Leukemias and Lymphomas. In: Pizzo PA, Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;113-30.
  • References2. Rabin KR, Gramatges MM, Margolin JF, Poplack DG. Acute Lymphoblastic Leukemia. In Pizzo PA, Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;463-97.
  • References3. Arceci RJ, Meshinchi S. Acute Myeloid Leukemia and Myelodysplastic Syndromes. In: Pizzo PA and Poplack DG, Eds. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia: Wolters Kluwer. 2016;498-544.
There are 3 citations in total.

Details

Primary Language English
Subjects Haematology
Journal Section Research
Authors

Burcu Genç This is me

Ayşe Özkan 0000-0003-1181-8169

İbrahim Bayram 0000-0003-0330-4766

Gülay Sezgin 0000-0003-2396-5692

Serhan Küpeli 0000-0001-7271-1803

Atila Tanyel,i 0000-0001-9526-2035

Publication Date March 31, 2021
Acceptance Date November 24, 2020
Published in Issue Year 2021 Volume: 46 Issue: 1

Cite

MLA Genç, Burcu et al. “Flow Cytometric Evaluation and Outcomes of Pediatric Acute Leukemia Patients”. Cukurova Medical Journal, vol. 46, no. 1, 2021, pp. 149-5.